News
Press Releases
Found 22 Results
March 15, 2022
ROCKVILLE, Md., Mar. 15, 2022 – OncoC4, Inc. is recognized by Pharma Tech Outlook as one of the “Top 10 Immunotherapy […]
February 18, 2022
ROCKVILLE, Md., Feb. 18, 2022 – OncoC4, Inc. is elated to announce that its co-founder and Chief Medical Officer, Dr. Pan […]
November 9, 2021
ROCKVILLE, Md., Nov. 09, 2021 — OncoC4, Inc., a clinical stage biopharma company focusing on immuno-oncology of cancer, reports a […]
May 27, 2021
SHANGHAI and ROCKVILLE, Md., May 26, 2021 — WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, […]
November 23, 2020
KENILWORTH, N.J., & ROCKVILLE, Md.–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and OncoImmune, a privately-held, […]